发明名称 BRCA1 mRNA EXPRESSION PREDICTS SURVIVAL IN PATIENTS WITH BLADDER CANCER TREATED WITH NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY
摘要 The invention relates to methods for predicting the clinical outcome of a patient which suffers from bladder cancer based on the expression levels of BRCA1 wherein high BRCA1 expression levels are indicative of a poor prognosis. Moreover, the invention relates to methods for predicting the response to chemotherapy of a patient which suffers from bladder cancer based on the expression levels of BRCA1, in particular, in patients which have been treated with chemotherapy prior to surgical removal of the tumor.
申请公布号 US2011059459(A1) 申请公布日期 2011.03.10
申请号 US20090918752 申请日期 2009.02.20
申请人 TARON ROCA MIGUEL;ROSELL COSTA RAFAEL 发明人 TARON ROCA MIGUEL;ROSELL COSTA RAFAEL
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址
您可能感兴趣的专利